| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Molecular Immunology and
Immunobiology, Immunex Corporation, Seattle, WA 98101
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
There is increasing evidence that the intestinal microflora is an important cofactor in the pathogenesis of intestinal inflammation. The development of spontaneous colitis in many mouse models can be prevented if mice are generated and maintained in a germfree environment or treated with oral antibiotics, highlighting the central role for bacterial colonization in the initiation and/or perpetuation of experimental IBD (4, 12, 13, 14, 15, 16). There is also evidence that human patients with IBD suffer from adverse and enhanced reactivity to their autologous resident intestinal flora (1, 2, 17). Considering that the cells of the mucosal immune system are protected from the large antigenic load in the gut lumen by a single layer of epithelial cells, it seems reasonable to assume that epithelial cells play a major role in providing a barrier that regulates contact between bacteria and immune cells. In support of this, transgenic mice expressing a mutant cadherin on their epithelial cells in the small intestine spontaneously develop IBD, presumably due to breaches occurring within the epithelial cell barrier (18). Thus, proteins expressed in epithelial cells may in some way contribute, directly or indirectly, to maintaining the protective barrier.
Intestinal epithelial cells and some lymphocyte subsets have been shown to express multiple drug resistance (MDR) genes (19, 20, 21, 22, 23, 24). These genes belong to a family of transporters known as ATP binding cassette transporters, which are characterized by their ability to pump small amphiphilic and hydrophobic molecules across membranes in an ATP-dependent manner (25, 26). MDR genes were first identified by their ability to confer resistance to chemotherapeutic agents in tumors and neoplastic cell lines (27). Three MDRgenes have been identified in rodents and two in humans, each of which has a restricted pattern of tissue expression and, most likely, a different function. Although it is well known that some of these gene products (MDR1 in humans and mdr1a and mdr3 in mice) can actively pump toxic drugs out of cells, their natural in vivo role has not been fully elucidated (28, 29). In mice, mdr1a is expressed on many tissues including intestinal epithelial cells, CD8+ T cells, a subset of CD4+ T cells, hematopoietic cells, and cells at the blood-brain barrier (19, 21, 23, 30, 31). The function of mdr1a in each of these different cell types and tissues is unknown.
Recently, mice with a targeted deletion of the mdr1a gene were generated (32). Analysis of these knockout mice has revealed that they have an increased sensitivity to certain drugs, but do not appear to show any constitutive abnormalities (31, 32, 33, 34). In the current study we observe that mdr1a-/- mice housed under specific pathogen-free (SPF) conditions develop spontaneous intestinal inflammation. We describe the nature of the inflammatory cell infiltrate, describe a role of the intestinal microflora in the initiation and perpetuation of colitis in these mice, and provide evidence that the development of colitis appears to arise as a result of a defect in the intestinal epithelial barrier.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
FVB control mice and mdr1a-/- mice were initially purchased from Taconic Farms (Germantown, NY) and then bred and maintained in the SPF facility at Immunex (Seattle, WA) in accordance with approved ethical guidelines. mdr1a-/- mice had been backcrossed onto the FVB strain for at least seven generations at Taconic Farms before shipping. Control and knockout mice used for experiments were age matched and received treatment simultaneously. Mice were monitored on alternate days for the presence of diarrhea and mucous discharge from the anus. All mice were bred and maintained under SPF conditions in Thoren isolation racks under positive pressure and fed autoclaved food and water ad libitum. The quality of the SPF facility is monitored through the Charles River Health Monitoring Plus program (Charles River, Wilmington MA) using the Charles River tracking profile. Sentinel mice receiving bedding from donor cages are tested for viral, parasite, and bacterial infection. There were no viruses, parasites, or pathogenic bacteria detected in our colony throughout the course of the study. Of particular note, we did not detect any evidence of Helicobacter infection (Helicobacter bilis, Helicobacter hepaticus, or Helicobacter spp.) in any mice.
Treatment of mice with oral antibiotics
Streptomycin sulfate (1.25% w/v), neomycin (1% w/v), bacitracin (1% w/v), and amphotericin (0.25% w/v) were dissolved in autoclaved drinking water (pH 2.5–2.8) supplemented with saccharine (1% w/v) and then filtered through a 0.22 µm Nalgene filter (Nalgene, Milwaukee, WI). As a control, mice received saccharine alone (1% w/v) in the drinking water. All reagents were obtained from Sigma (St. Louis, MO). Regular drinking water was replaced with antibiotic or saccharine drinking water during treatment.
Antibodies
The following primary Abs were used for flow cytometric analysis
and immunoperoxidase histochemistry: anti-CD4 (rat IgG; L3T4),
anti-CD8
(rat IgG; 53-6.7), anti-TCRß (hamster IgG;
H57-597), anti-TCR
(hamster IgG; GL3), anti-GR1 (rat IgG;
RB6–8C5), anti-B220 (CD45R) (rat IgG; RA3–6B2), and
anti-CD3
(hamster IgG; 500A2; Immunex). The primary Abs were
conjugated either with biotin or R-phycoerythrin (PE). All Abs
were obtained from PharMingen (San Diego, CA) except where indicated.
The following secondary Abs were used for immunoperoxidase
histochemistry: biotinylated sheep anti-rat IgG (Amersham,
Arlington Heights, IL) and biotinylated goat anti-hamster IgG
(Caltag, South San Francisco, CA).
Flow cytometric analysis of isolated cells
Isolated cells were incubated with the appropriate PE- or biotin-conjugated primary Ab for 30 min on ice in PBS supplemented with 5% BSA and 0.02% sodium azide essentially as described previously (35). Stained cells were washed two times, incubated with streptavidin-allophycocyanin (Molecular Probes, Eugene, OR), and then fixed in 1% paraformaldahyde before analysis. Stained cells were analyzed on a Becton Dickinson FACScan flow cytometer (Immunocytochemistry Systems, San Jose, CA) using Becton Dickinson Cellquest software.
Rhodamine efflux assay
Lymphocytes were isolated from mice and incubated with 0.4 µg/ml rhodamine 123 (Sigma) for 15 min at 37°C in complete RPMI 1640 supplemented with 10% FCS. For two-color analysis, cells were simultaneously stained with PE-conjugated primary Abs. The stained, rhodamine-loaded cells were then washed two times and incubated in complete medium without rhodamine 123 for an additional 2 h at 37°C. Cells were then washed two times in complete medium and analyzed on a Becton Dickinson FACScan flow cytometer (Immunocytochemistry Systems) using Becton Dickinson Cellquest software.
Immunoperoxidase histochemistry analysis of frozen sections
Large intestines were removed, embedded in OCT compound (Tissue-Tek, Torrence, CA), frozen in a dry ice/ethanol bath, and stored at -80°C until use. Frozen sections (5 µm) of intestine were cut, fixed for 15 min in acetone, and stored at -80°C until staining. Peroxidase staining was performed using the Vectastain ABC system (Vector Laboratories, Burlingame, CA) according to specified directions as described previously (35). Briefly, tissue sections were preincubated in 5% goat serum, 5% bovine serum, and 1% mouse serum for 30 min at room temperature and then incubated with biotin-conjugated primary Ab for 1 h at room temperature. Slides were washed three times in Tris-buffered saline, further incubated with a biotin-conjugated secondary Ab for 30 min at room temperature, and washed again three times in Tris-buffered saline. Sections were then incubated with avidin peroxidase (Vectastain ABC system), washed, and finally incubated with diaminobenzidine substrate (Sigma) before counterstaining in hematoxylin. Positive cells were identified by the presence of a brown reaction product.
Immunofluorescence analysis of frozen sections
Tissues were frozen in liquid nitrogen as described above, and 5-µm cryosections were cut, air dried, and acetone fixed before staining. Tissue sections from both mdr1a-/- and control FVB mice were stained with either 20 µg/ml FITC-conjugated anti-MDR mAb (C219; Signet Laboratories, Dedham, MA) or FITC-conjugated IgG2a isotype control mAb (PharMingen) in the presence of 2 mM TOTO-3 (Molecular Probes) and 30% mouse serum. Sections were visualized using a confocal laser scanning microscope (Molecular Dynamics, Sunnyvale, CA).
Intraepithelial lymphocyte (IEL) and lamina propria lymphocyte (LPL) cell isolations
IEL were isolated according to a modification of published procedures (35, 36). Briefly, the small and large intestines were removed and washed in Ca2+/Mg2+-free HBSS (Life Technologies, Bethesda, MD). Peyer’s patches were removed, and the intestines were opened longitudinally, cut into 0.5-cm pieces, and placed in 1 mM EDTA in Ca2+/Mg2+-free HBSS at 37°C for three sequential 15-min incubations with intermittent vortexing to remove epithelial cells and IEL. Supernatants were collected and pooled for IEL purification. The remaining tissues were then washed in PBS and incubated in trypsin-EDTA two times to remove any residual epithelial cells, and the denuded tissues were digested with 90 U/ml collagenase type VIII (Sigma) in RPMI 1640/10% FCS for three sequential 20-min incubations at 37°C with intermittent vortex mixing to release LPL. Supernatants were collected and pooled for LPL purification. IEL and LPL were purified by passing cells over a prewet glass wool column before spinning them through a 40%/80% discontinuous Percoll gradient (Pharmacia, Uppsala, Sweden) as previously described (35). The cells at the 40%/80% interface were collected, washed, and resuspended in complete medium for analysis.
Intestinal bacterial Ag preparation
Intestinal bacterial Ags were prepared from fecal contents harvested from the cecum according to a modification of published procedures (37). Briefly, individual preparations were processed from three different mouse sources: 1) an FVB control mouse, 2) an mdr1a-/- mouse with no signs of inflammation, and 3) an mdr1a-/- mouse with active colitis. The cecal contents from the individual mice were placed in a 2-ml bead shaker tube half-filled with 2-µm zirconium beads suspended in PBS. The mixture was vortexed in a bead beater (Biospec Products, Bartlesville, OK) for 30 s at 5000 rpm and placed on ice. The intestinal bacterial slurry was then microfuged at 14,000 x g, and the supernatant was harvested and filtered through a 0.22 µm filter. The relative protein content in each sample was estimated using a Bradford assay (Bio-Rad, Hercules, CA).
Proliferation assay
Cell suspensions were prepared by gently mashing mesenteric lymph nodes (MLN) between ground glass slides and passing them through nylon mesh. MLN cells were cultured at a density of 2 x 105 cells/well in 96-well flat-bottom plates in complete RPMI supplemented with 10% FCS in a final volume of 200 µl in a humidified 6% CO2 incubator at 37°C for 48 h. Cells were cultured either in the presence of titrating amounts of intestinal bacterial Ag preparations, in the presence of 1 µg/ml Con A, or in anti-CD3 mAb-coated wells (1 µg/ml). Proliferation was assessed by addition of 1 µCi/well [3H]TdR 18 h before harvesting using a Matrix-96 cell harvester (Inotech, Lansing, MI). The amount of radioactivity incorporated into DNA was measured using a direct ß counter (Packard, Meriden, CT). All cultures were performed in triplicate. Data are reported as mean cpm ± 1 SD of triplicate wells.
Serum Ab titers
Mice were exsanguinated, and the serum was collected. Polyclonal serum Ab titers were determined by isotype-specific ELISAs for IgA, IgE, IgG1, IgG2a, IgG2b, IgG3, and IgM as previously described (38). Briefly, 96-well Nunc Maxisorp plates (Nunc, Naperville, IL) were coated overnight at 4°C with isotype-specific anti-mouse Ig Abs (0.2 mg/well), blocked with PBS/10% FCS for 2 h at room temperature, and washed with PBS/0.1% Tween-20. Serum samples and control samples were serially diluted in PBS/10% FCS starting at 1:100. Plates were incubated for 2 h at room temperature, washed, and incubated with the appropriate peroxidase-conjugated specific anti-isotype detecting Ab for an additional 2 h at room temperature. Plates were washed again, and enzyme activity was detected using TMB microwell peroxidase substrate reagents (Kirkegaard & Perry Laboratories, Gaithersburg, MD) and 2 N H2SO4. The amount of reaction product was assessed on an ELISA plate reader at OD 450 nm using the Deltasoft program (DeltaPoint, Monterey, CA). The affinity-purified Abs used for determining isotype-specific serum Ab titers by ELISA were obtained from Southern Biotechnology Associates (Birmingham, AL), except for anti-IgE, which was obtained from Serotec (Oxford, U.K.), and antiIgG2a, which was obtained from PharMingen. Ig concentrations were determined by comparing test sample dilution curves with known concentrations of isotype controls. Results are indicated as mean concentration ± 1 SD of two separate mice for each group.
Bone marrow chimeric mice
mdr1a-/- mice and FVB mice were irradiated with 10 Gy using a 137Cs source, rested for 4–6 h, and then reconstituted by i.v. injection with 2 x 106 bone marrow cells collected from the femurs of appropriate donors.
Bacterial identification
Analysis of cecal and colonic bacteria (Phoenix Laboratories, Everett, WA). Mice were killed under sterile conditions, and aerobe/anaerobe bacterial culture swabs (Medical Wire and Equipment, Corsham, Wilts, U.K.) were used to collect cecal and colonic contents. Samples were shipped to Phoenix Laboratories for identification of aerobic and anaerobic bacterial outgrowth. At Phoenix Laboratories, swabs were streaked and bacterial species were identified based on nutrient requirements, growth, morphology, and staining properties.
Analysis of colonic bacteria (Microcheck, Northfield, VT). Mice were killed under sterile conditions, and colonic washout samples were harvested and shipped to Microcheck for bacterial identification by microbial cellular fatty acid analysis. Samples were subcultured at Microcheck, and microbial fatty acid profiles were determined by high-resolution gas chromatography. Identification of bacteria in individual samples was determined by comparing the fatty acid profiles of the unknown sample with known profiles from microbial fatty acid libraries.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Efflux of rhodamine 123 from preloaded lymphocytes has been used
to demonstrate the presence of mdr activity in peripheral T
cells (19, 30). However, the assay does not distinguish whether
rhodamine efflux is due to mdr1a activity, mdr3
activity, or perhaps even another unidentified transporter. We
therefore analyzed rhodamine 123 efflux in lymphocytes from normal FVB
mice and mdr1a-/- mice to determine whether
rhodamine 123 efflux was associated with a functional mdr1a
gene and to identify which mucosal and peripheral lymphocyte subsets
might exhibit the pump activity. mdr1a-associated functional
activity was detected in MLN cells from normal FVB mice but not from
mdr1a-/- mice, as determined by ability to
efflux rhodamine 123 (Fig. 1
A). These data indicate that
a functional mdr1a gene product is necessary for rhodamine
123 efflux. To determine which subsets of mucosal lymphocytes have the
mdr1a activity, we performed the rhodamine efflux assay on
IEL and LPL isolated from the large intestines of FVB mice. We
simultaneously stained these cells with mAbs against CD3, CD4, CD8,
TCRß, and TCR (Fig. 1B). The individual CD3, CD4,
CD8, TCRß, and TCR subsets within the IEL and LPL
compartments had similar efflux profiles. Virtually all of the
CD8+ cells and TCR+ cells appeared to
exhibit mdr activity and efflux rhodamine 123, whereas only
half of the CD4+ cells and half of the
TCRß+ cells were able to efflux the dye. None of the
mucosal lymphocyte populations from the
mdr1a-/- mice were able to efflux the
rhodamine 123 (data not shown), further suggesting that
mdr1a is necessary for rhodamine 123 efflux activity in
mucosal lymphocytes.
|
shows
mdr1a staining (green) on transverse sections of colons from
FVB control (+/+) and mdr1a-deficient (-/-) mice. The
sections were counterstained with TOTO-3 (red) to visualize gut
architecture. mdr1a staining appears to be restricted to the
apical surface of epithelial cells in FVB mice. No mdr1a
staining was apparent on sections from
mdr1a-/- mice or on sections from FVB mice
stained with an isotype control (data not shown). We were also unable
to detect any mdr1a staining on LPL or on IEL in FVB mice,
despite functional evidence that these cells express mdr1a
(see above). It is unclear whether this was due to low expression
levels of mdr1a on mucosal lymphocytes or to the relatively
low frequency of lymphocytes within each section.
|
Approximately 20–25% of the 169 mdr1a knockout mice
included in this part of the study appeared to develop loose stools and
anal mucous discharge by 1 year of age (Table I). Histologic analysis of mice with
clinical signs of colitis confirmed the presence of active intestinal
inflammation that was primarily restricted to the large intestine. The
difference in incidence between males (20%) and females (26%) was not
significant. The average age at onset was approximately 20 wk, although
the first signs of colitis development could be seen in mice ranging
between 8 and 36 wk of age. Although some mice with colitis developed a
wasting-type disease, the majority of colitic animals were maintained
for up to 3 mo without signs of cachexia. Disease was nontransmissible,
since mdr1a-/- mice both with and without
colitis were housed in the same cage. We observed no clinical or
histologic signs of colitis in any FVB control mice, heterozygous
mdr1a+/- mice, or other immunocompetent mouse
strains of any age housed within the facility.
|
The severe inflammation of the large intestine that develops in
mdr1a-/- mice bears resemblance to the human
IBD, ulcerative colitis. Histopathologic analysis of multiple colitic
mdr1a-/- animals revealed inflammation spread
along the entire length of the colon. The intestinal inflammation was
characterized by a massive thickening of the mucosa and evidence of
inflammatory cell infiltrates into the lamina propria in
mdr1a-/- mice with active colitis (Fig. 3a) compared with
mdr1a-/- mice without colitis (Fig. 3b). Occasional crypt abscesses and ulcerations extending
through the mucosa to the muscular layer were also often noted in the
colitic animals (Fig. 3c). Crypt length was greatly
increased in colitic animals, with approximately three- to fivefold
more epithelial cells per crypt in colitic mice (Fig. 3a)
compared with noncolitic mice (Fig. 3b). There also appeared
to be some evidence of dysregulated epithelial cell growth in colitic
mdr1a-/- mice in areas of inflammation (Fig. 3d).
|
). There was an increased number of
infiltrating CD3+ T cells scattered diffusely throughout
the lamina propria of inflamed colonic tissue from mice with active
colitis (Fig. 4a) compared with colonic tissue from control
FVB mice (Fig. 4c). A less dramatic CD3+ T cell
infiltrate was observed in mice with early colitis (Fig. 4b).
|
ß+ (Table II). Although there was an apparent
decrease in the relative proportion of CD8+ T cells in the
lamina propria of colitic animals, the absolute number of
CD8+TCRß+ T cells was not diminished,
probably owing to the fourfold increase in the total number of LPL
isolated from colitic animals (data not shown). There was no apparent
increase in TCR+ T cells in the inflamed tissue (data
not shown).
|
d) compared with control FVB animals (Fig. 4f). Whereas the T cells were diffusely scattered throughout
the lamina propria, the B cell infiltrates appeared to be localized to
follicular clusters within the mucosa. The follicular clusters varied
in size and were only observed in the colon. In contrast to animals
with fully developed colitis, animals with intermediate colitis mostly
had individual B220+ cells scattered throughout the lamina
propria and the few clusters that were present were reduced in size
(Fig. 4e).
Gr1+ cellular infiltrates were also prominent
throughout the lamina propria of the large intestine in mice with
active colitis (Fig. 4g) compared with control FVB mice,
which appeared devoid of Gr1+ cells (Fig. 4i).
The Gr1+ infiltrates were uniformly present throughout the
lamina propria, although an increased number of cells did appear to be
migrating across the epithelium into the gut lumen in regions where the
epithelialbarrier may have been compromised (Fig. 4g). Mice
with early colitis had relatively few Gr1+ infiltrating
cells, and these were restricted to small focal regions in the
lamina propria (Fig. 4h).
Prophylactic treatment with oral antibiotics can prevent spontaneous colitis in mdr1a-/- mice
It has been well established in a majority of mouse models that spontaneous colitis can be prevented if mice are housed under germfree conditions, suggesting that the presence of the gut flora is necessary for the development of colitis (4, 12, 14). It has also been previously demonstrated in another model of spontaneous colitis that treating mice with antibiotics can prevent inflammation (13). In the first part of the study, we treated mdr1a-/- mice with broad-spectrum oral antibiotics to eliminate the commensal gut flora and then monitored for the development of colitis. Control mice were given water treated with saccharine alone. None of the mice had detectable colitis at the beginning of the study.
The incidence of colitis in mdr1a-/- mice
treated with antibiotics was greatly reduced compared with
mdr1a-/- mice treated with saccharine alone
(Fig. 5). In the 16-wk treatment, 14 of
31 saccharine-treated mdr1a-/- mice developed
colitis (loose stools and mucous discharge), whereas only 1 of 39
antibiotic-treated mdr1a-/- mice developed any
signs of inflammation (no clinical signs, histopathologic evidence
only). The one antibiotic-treated mdr1a-/-
mouse that showed signs of colitis had only one minor focal region of
inflammatory cell accumulation (data not shown) and did not show any
other overt signs of intestinal disease.
|
To ascertain whether the intestinal inflammation in mice with
active colitis could be reversed by antibiotic treatment, mice with
active colitis (as determined by evidence of loose stools and mucous
discharge from the anus) were therapeutically treated with antibiotics
in the drinking water. Within 3 wk of continuous antibiotic therapy,
the previously colitic mice had no residual visible signs of anal
discharge or loose stools. To determine whether the pathology
associated with colitis could also be reversed along with the gross
symptoms, mice treated with antibiotics for 10 wk were killed and the
colons analyzed histopathologically. As expected, the colons of
untreated colitic animals were grossly thickened (Fig. 6a), compared with control
animals (Fig. 6b). Interestingly, the gross thickening of
the colon associated with active IBD was significantly reduced in mice
that had received therapeutic antibiotic treatment (Fig. 6c). On further histopathologic examination of these
intestines, we observed little evidence of inflammation, and the
general gut architecture appeared similar to that of control mice (data
not shown). Immunohistochemical analysis revealed that the mice treated
with antibiotics had no evidence of persisting Gr1+
infiltrates or B cell follicles (data not shown). However, despite the
apparent reduction in inflammation arising from antibiotic treatment,
there still appeared to be an increased number of CD3+ T
cells in the lamina propria of these animals (Fig. 6d)
compared with control mice (Fig. 4c).
|
Although the commensal bacterial flora resident in the intestinal
lumen of the gut appears to play a major role in the induction of
colitis, little is known about the role of individual bacteria in the
initiation and perpetuation of intestinal inflammation. In this study
we analyzed the bacterial flora present in the cecum and colon of
mdr1a-/- mice with colitis,
mdr1a-/- mice with no evidence of active
colitis, and control FVB mice. Table III
lists the major bacterial species recovered from the animals. All of
the mice appeared to have a gut bacterial profile devoid of any
pathogenic organisms.
|
In vitro proliferative reactivity of cells from the gut-associated lymphoid tissue following stimulation with intestinal bacterial Ags
Since bacterial colonization of the intestine appears to be
crucial for the initiation of spontaneous colitis in
mdr1a-/- mice, we analyzed the in vitro
proliferative response of cells isolated from the MLNs following
stimulation with intestinal Ags (Fig. 7). Intestinal Ags were prepared
from cecal contents obtained from FVB control mice,
mdr1a-/- mice with no overt signs of colitis,
and mdr1a-/- mice with active colitis. MLN
were removed from the same animals, and cell suspensions were tested
for proliferative reactivity against each of the intestinal bacterial
Ag preparations.
|
mdr1a-/- mice with active colitis have increased serum Ab titers
The increased frequency of B cell clusters in the lamina propria of colitic animals suggests that there may be a dysregulated humoral response in these animals. To test this, we measured the serum Ab titers of colitic, noncolitic, and control animals. Each of the Ig isotype levels was assessed by ELISA. All of the serum Ig isotype levels were elevated in colitic animals compared with control FVB mice or mdr1a-/- mice without colitis, suggesting polyclonal activation of B cells associated with colitis. Serum IgA and IgG1 levels appeared most elevated in the mice with active colitis, although IgG2a, IgG2b, IgM, and IgE levels were also increased over control mice (Fig. 8).
Spontaneous colitis correlates with a lack of mdr1a expression on intestinal epithelial cells
Given that mdr1a is expressed on both lymphocytes and
epithelial cells in the large intestine, we sought to determine whether
the spontaneous development of colitis was the result of an
mdr1a defect within the lymphoid or within the epithelial
cell population. We generated irradiation bone marrow chimeras in which
irradiated FVB animals were reconstituted with bone marrow from
mdr1a-/- or FVB donors, or irradiated
mdr1a-/- mice were reconstituted with bone
marrow from FVB or mdr1a-/- donors. As
controls, additional groups of mice were generated in which FVB mice
were reconstituted with FVB bone marrow and
mdr1a-/- mice were reconstituted with
mdr1a-/- bone marrow. The incidences of
colitis in the groups are listed in Table IV. mdr1a-/-
mice that were reconstituted with wild-type bone marrow developed signs
of colitis within 12 wk after reconstitution. After being maintained
for 52 wk, 25% of the mice had developed active colitis. In contrast,
two groups of FVB mice, which were reconstituted with
mdr1a-/- bone marrow, were maintained for up
to 38 wk without any overt signs of colitis. As expected, the control
FVB mice reconstituted with FVB bone marrow did not develop colitis.
Surprisingly, 100% of the mdr-/- mice
reconstituted with mdr1a-/- bone marrow
developed colitis. The reason for the increased incidence in the latter
group compared with unmanipulated mdr1a-/-
mice is unclear, although it is possible that radiation damage to the
mucosa sufficiently enhanced susceptibility to developing colitis.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
ß+ cells (5) or the cytokines IL-2 (6) or IL-10 (4)
and in mice deficient for the G2i signaling protein
(42). In addition, IBD occurs in human CD3-transgenic mice
reconstituted with normal bone marrow (7), in HLA-B27 transgenic rats
(43), and in immunodeficient SCID mice reconstituted with
CD4+CD45RBhigh cells (9, 12, 44). The great
diversity of these models implies that there are complex mechanisms
regulating the various components of the mucosal immune system that
create and maintain a homeostatic balance. Disruption of this balance
in any number of ways can obviously lead to the development of an
adverse inflammatory response.
Here we describe a novel model of spontaneous colitis occurring in
mdr1a-/- mice that is characterized by a broad
inflammatory response that appears restricted to the entire length of
the colon. The histopathology of the inflammation is most consistent
with features associated with ulcerative colitis in humans and is
characterized by dysregulated epithelial cell growth, ulcerations,
crypt abscesses, and lymphocytic infiltration into the mucosa. Given
the large number and diverse nature of the IBD models, it is not
surprising that there is some controversy regarding the precise nature
of the cells responsible for initiating and perpetuating IBD. The
diffuse lymphocytic infiltrates in the
mdr1a-/- mice are primarily
CD4+TCRß+ T cells and Gr1+
cells. In addition, follicular B cell clusters are prominent throughout
the mucosa.
mdr1a-/- mice require a commensal bacterial
flora for the development of colitis. Colitis can be prevented in
mdr1a-/- animals by oral treatment with
broad-spectrum antibiotics to eliminate intestinal bacteria. The
requirement for bacterial flora in the induction of colitis in
mdr1a-/- mice is consistent with many of the
other IBD models. IBD does not develop in the TCR or IL-10 knockout
animals maintained under germfree conditions (4, 14), and IBD can be
prevented in the CD4+CD45RBhigh SCID transfer
model if the animals have a reduced number of enteric flora or are
treated with broad-spectrum antibiotics (12, 13). In addition to
preventing the initiation of IBD, we show here that antibiotic
treatment can therapeutically reverse colitis in
mdr1a-/- mice with active inflammation. This
indicates that intestinal flora is not only necessary for initiating
inflammation but is also required for sustaining the inflammatory
response. Interestingly, despite the reversal of inflammation, a large
number of CD3+ T cells remain present in the mucosa. The
functional state of these T cells is unclear.
In the course of this study, we observed a relatively high incidence of colitis in mdr1a-/- mice treated with saccharine compared with unmanipulated knockout mice in the colony. We have no definitive explanation for this, since there is no a priori reason why saccharine should make animals more susceptible to developing colitis. However, it is possible that changes do occur in the commensal flora when saccharine is included in the drinking water, perhaps permitting outgrowth of certain bacterial species. Despite the increased incidence of colitis in the saccharine-treated mice, the addition of antibiotics was sufficient to eliminate the problem and prevent both the development of colitis and reverse ongoing intestinal inflammation.
It is possible that an individual bacterial species that colonizes the intestine might be responsible for initiating inflammation in these murine IBD models. To determine whether there might be a specific bacterial pathogen associated with disease in the mdr1a-/- mice, we analyzed the bacterial composition of the resident cecal and colonic flora in colitic and noncolitic mdr1a-/- mice and control FVB mice. We were not able to identify a single bacterial species that could be solely responsible for triggering intestinal disease. There did appear to be variations in the relative abundance of certain bacterial species in the different samples analyzed, and while it remains possible that an excess of a singular species might be responsible for the initiation of colitis, this may simply reflect a selective advantage for certain bacteria in the local microenvironment during intestinal inflammation.
Another potential explanation for the requirement of intestinal flora
in the induction of IBD is that cross-reactive epitopes may exist
between intestinal flora and enterocytes, such that the enterocytes
become the target of an autoimmune inflammatory response. In support of
this, IBD in TCR knockout mice is accompanied by the appearance of
autoAbs, including those directed against epithelial cell
proteins (8, 45). mdr1a-/- mice with active
colitis have large B cell follicles in the lamina propria. These mice
also have a massive increase in serum Ab titers of all isotypes,
suggesting a polyclonal activation of B cells; however, it is unclear
whether the Ab response is directed against intestinal tissues. We are
currently breeding the mdr1a-/- mice with B
cell-deficient mice to determine whether B cell activation is a
critical component in the initiation of colitis.
Since data from many of the other IBD models indicate that T cells are a major component in the induction of IBD, and much of the intestinal damage in IBD appears to be the result of T cell-mediated injury (46, 47), we decided to analyze the functional activity of T cells isolated from mdr1a-/- mice with active colitis. Lymphocytes isolated from animals with active inflammation appeared to be significantly more responsive to intestinal bacterial Ags compared with control animals. Lymphocytes isolated from mdr1a-/- mice without active inflammation had a similar proliferative reactivity compared with control FVB animals. This indicates that the mdr1a defect does not inherently cause hyperresponsiveness to bacterial Ags. Rather, it appears that lymphocytes become hyperresponsive to bacterial stimulation only after the onset of inflammation. The finding that bacterial Ags prepared from animals with colitis and animals without colitis were equally potent in stimulating proliferation further suggests that colitis is probably not caused by a single pathogenic organism.
A central question in the mdr1a-/- mouse IBD
model is, where does the defect that leads to colitis reside?
mdr genes are expressed on a number of immune and nonimmune
cell types in mice and humans (19, 20, 21, 23). Thus, it is possible that
mdr1a may have several different functional activities
depending on the site of expression. We show here that mdr1a
is expressed on murine peripheral and mucosal T lymphocytes including
all TCR+ and CD8+ cells and a proportion
of TCRß+ and CD4+ cells. Despite the lack
of mdr1a expression on immune cells in the
mdr1a-/- mice, the immune system does not
appear to have any gross phenotypic or functional defects. It is known
that mdr1a is also expressed on the apical surface of
colonic epithelial cells, where it has been shown to actively pump
orally administered toxins into the lumen of the gut (48). There is
also evidence that mdr1a may play a role in Cl-
channel regulation in epithelial cells (49, 50, 51). Thus, we thought it
possible that mdr1a-/- mice have functional
defects within the intestinal epithelial barrier that might ultimately
lead to colitis. To assess whether immune or epithelial cell defects
were responsible for the susceptibility to colitis in
mdr1a-/- mice, we generated a series of
chimeric mice. Irradiated mdr1a-/- mice
reconstituted with wild-type bone marrow spontaneously developed
colitis. In contrast, irradiated wild-type mice reconstituted with
mdr1a-deficient bone marrow cells did not develop colitis.
These data clearly suggest that the defect that leads to the initiation
of colitis in mdr1a-deficient mice is concordant with
defective mdr1a expression on a radiation-resistant element
within the host, most likely the epithelial cells lining the gut. These
data also suggest that the colitis in mdr1a-/-
mice is not likely to be associated with immune cell deficiencies.
The precise mechanistic defect causing colitis in the mdr1a-/- mice is unclear. One possibility is that bacterial products/toxins become sequestrated within epithelial cells, since small amphiphilic, hydrophobic molecules are less likely to be secreted in the absence of a functional mdr pump. It is not unreasonable to assume that a buildup of bacterial products within mdr1a-defective epithelial cells could subsequently initiate an inflammatory response, either by direct toxicity to the epithelial cell or indirectly by altering the nature of the Ag-presenting capability of the epithelial cell. The demonstrated requirement for bacterial flora in the initiation and progression of the inflammation, and the association of disease with defective mdr1a expression in epithelial cells, suggests that one of these scenarios might be true. We are currently attempting to ascertain the precise function of mdr1a in colonic epithelial cells.
With all of the different immune models of colitis, it has become apparent that the intestinal microenvironment is an exquisitely regulated system and that perturbation of individual components within this environment can lead to inflammation. The model described here has many similarities with existing murine models of spontaneous colitis, including an inflamed pathology restricted to the colon and a dependence on intestinal flora. In contrast to most existing IBD models, the immune system of mdr1a-/- mice does not have any gross abnormalities. Furthermore, this model reveals that disruption of a nonimmune component of the mucosal environment can also be responsible for the initiation of colitis. The mdr1a knockout mouse model of spontaneous colitis should provide us with insight into the role of the epithelial barrier in preventing aberrant immune responses to commensal bacterial, and possibly food, Ags. Moreover, it predicts a possible in vivo functional role for mdr1a in the maintenance of the intestinal epithelial barrier.
|
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Abbreviations used in this paper: IBD, inflammatory bowel disease; mdr, multiple drug resistance; SPF, specific pathogen free; PE, phycoerythrin; IEL, intraepithelial lymphocyte; LPL, lamina propria lymphocyte; MLN, mesenteric lymph node.
Received for publication April 27, 1998. Accepted for publication July 9, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
mutant mice with inflammatory bowel disease. J. Exp. Med. 183:847.ß-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150:91.[Abstract]
/ß+ and /+ T cells in murine intestinal epithelium. Eur. J. Immunol. 20:1623.[Medline]
ß(+) T cells. Nature 369:654.[Medline]
ß T cells in SCID mice with colitis. Eur. J. Immunol. 26:3074.[Medline]
80-kDa mdr1a gene product. J. Biol. Chem. 271:3300.This article has been cited by other articles:
|
|
 |
|
  H. Blokzijl, A. van Steenpaal, S. V. Borght, L. I. H. Bok, L. Libbrecht, M. Tamminga, M. Geuken, T. A. D. Roskams, G. Dijkstra, H. Moshage, et al. Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease J. Biol. Chem., December 19, 2008; 283(51): 35630 - 35637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pazos, D. Siccardi, K. L. Mumy, J. D. Bien, S. Louie, H. N. Shi, K. Gronert, R. J. Mrsny, and B. A. McCormick Multidrug Resistance-Associated Transporter 2 Regulates Mucosal Inflammation by Facilitating the Synthesis of Hepoxilin A3 J. Immunol., December 1, 2008; 181(11): 8044 - 8052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Siccardi, K. L. Mumy, D. M. Wall, J. D. Bien, and B. A. McCormick Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1392 - G1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Barnes, A. Vidrich, M.-L. Wang, G. D. Wu, F. Cominelli, J. Rivera-Nieves, G. Bamias, and S. M. Cohn Resistin-Like Molecule beta (RELMbeta/FIZZ2) Is Highly Expressed in the Ileum of SAMP1/YitFc Mice and Is Associated with Initiation of Ileitis J. Immunol., November 15, 2007; 179(10): 7012 - 7020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Raelson, R. D. Little, A. Ruether, H. Fournier, B. Paquin, P. Van Eerdewegh, W. E. C. Bradley, P. Croteau, Q. Nguyen-Huu, J. Segal, et al. From the Cover: Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci PNAS, September 11, 2007; 104(37): 14747 - 14752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. An, B. Wei, B. Xia, J. M. McDaniel, T. Ju, R. D. Cummings, J. Braun, and L. Xia Increased susceptibility to colitis and colorectal tumors in mice lacking core 3 derived O-glycans J. Exp. Med., June 11, 2007; 204(6): 1417 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Schmitz, V. J. McCracken, R. A. Dimmitt, and R. G. Lorenz Expression of CXCL15 (Lungkine) in Murine Gastrointestinal, Urogenital, and Endocrine Organs J. Histochem. Cytochem., May 1, 2007; 55(5): 515 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Shah, X. Ma, K. Morimura, I. Kim, and F. J. Gonzalez Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-{kappa}B target gene expression Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1114 - G1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Arnett, S. S. Escobar, E. Gonzalez-Suarez, A. L. Budelsky, L. A. Steffen, N. Boiani, M. Zhang, G. Siu, A. W. Brewer, and J. L. Viney BTNL2, a Butyrophilin/B7-Like Molecule, Is a Negative Costimulatory Molecule Modulated in Intestinal Inflammation J. Immunol., February 1, 2007; 178(3): 1523 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiol Rev, October 1, 2006; 86(4): 1179 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-T. Ho, N. Soranzo, E.R. Nimmo, A. Tenesa, D.B. Goldstein, and J. Satsangi ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach Hum. Mol. Genet., March 1, 2006; 15(5): 797 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Mueller and A J Macpherson Layers of mutualism with commensal bacteria protect us from intestinal inflammation Gut, February 1, 2006; 55(2): 276 - 284. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bamias, M. R. Nyce, S. A. De La Rue, and F. Cominelli New Concepts in the Pathophysiology of Inflammatory Bowel Disease Ann Intern Med, December 20, 2005; 143(12): 895 - 904. [Full Text] [PDF]
|
|
|
|
|
|
S. Resta-Lenert, J. Smitham, and K. E. Barrett Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G153 - G162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Maggio-Price, H. Bielefeldt-Ohmann, P. Treuting, B. M. Iritani, W. Zeng, A. Nicks, M. Tsang, D. Shows, P. Morrissey, and J. L. Viney Dual Infection with Helicobacter bilis and Helicobacter hepaticus in P-Glycoprotein-Deficient mdr1a-/- Mice Results in Colitis that Progresses to Dysplasia Am. J. Pathol., June 1, 2005; 166(6): 1793 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Fort, A. Mozaffarian, A. G. Stover, J. d. S. Correia, D. A. Johnson, R. T. Crane, R. J. Ulevitch, D. H. Persing, H. Bielefeldt-Ohmann, P. Probst, et al. A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease J. Immunol., May 15, 2005; 174(10): 6416 - 6423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Habtezion, D. M. Toivola, E. C. Butcher, and M. B. Omary Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment J. Cell Sci., May 1, 2005; 118(9): 1971 - 1980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Dixit, B. Zingarelli, D. J. Buckley, A. R. Buckley, and G. M. Pauletti Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G533 - G540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu and B. Chen Copper treatment alters the barrier functions of human intestinal Caco-2 cells: involving tight junctions and P-glycoprotein Human and Experimental Toxicology, August 1, 2004; 23(8): 369 - 377. [Abstract] [PDF]
|
|
|
|
 |
|
 B. L. Neudeck, J. M. Loeb, N. G. Faith, and C. J. Czuprynski Intestinal P Glycoprotein Acts as a Natural Defense Mechanism against Listeria monocytogenes Infect. Immun., July 1, 2004; 72(7): 3849 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-F. Chu, R. S. Esworthy, P. G. Chu, J. A. Longmate, M. M. Huycke, S. Wilczynski, and J. H. Doroshow Bacteria-Induced Intestinal Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes Cancer Res., February 1, 2004; 64(3): 962 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C G Dietrich, A Geier, and R P J Oude Elferink ABC of oral bioavailability: transporters as gatekeepers in the gut Gut, December 1, 2003; 52(12): 1788 - 1795. [Full Text] [PDF]
|
|
|
|
|
|
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G-T Ho, F M Moodie, and J Satsangi Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut, May 1, 2003; 52(5): 759 - 766. [Abstract] [Full Text]
|
|
|
|
|
|
R O. Elferink Cholestasis Gut, May 1, 2003; 52(90002): ii42 - 48. [Abstract] [Full Text]
|
|
|
|
|
|
T Ohkusa, I Okayasu, T Ogihara, K Morita, M Ogawa, and N Sato Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis Gut, January 1, 2003; 52(1): 79 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bamias, M. Marini, C. A. Moskaluk, M. Odashima, W. G. Ross, J. Rivera-Nieves, and F. Cominelli Down-Regulation of Intestinal Lymphocyte Activation and Th1 Cytokine Production by Antibiotic Therapy in a Murine Model of Crohn's Disease J. Immunol., November 1, 2002; 169(9): 5308 - 5314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Potocnik, M Ravnik-Glavac, R Golouh, and D Glavac Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers J. Med. Genet., May 1, 2002; 39(5): 340 - 346. [Full Text] [PDF]
|
|
|
|
|
|
M Waidmann, Y Allemand, J Lehmann, S di Genaro, N Bucheler, A Hamann, and I B Autenrieth Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-{gamma} and TNF-{alpha} production Gut, February 1, 2002; 50(2): 170 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Maggio-Price, D. Shows, K. Waggie, A. Burich, W. Zeng, S. Escobar, P. Morrissey, and J. L. Viney Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient (mdr1a-/-) Mice Am. J. Pathol., February 1, 2002; 160(2): 739 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Hendrickson, R. Gokhale, and J. H. Cho Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease Clin. Microbiol. Rev., January 1, 2002; 15(1): 79 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wei, H. Dalwadi, L. K. Gordon, C. Landers, D. Bruckner, S. R. Targan, and J. Braun Molecular Cloning of a Bacteroides caccae TonB-Linked Outer Membrane Protein Identified by an Inflammatory Bowel Disease Marker Antibody Infect. Immun., October 1, 2001; 69(10): 6044 - 6054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Burich, R. Hershberg, K. Waggie, W. Zeng, T. Brabb, G. Westrich, J. L. Viney, and L. Maggio-Price Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G764 - G778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Esworthy, R. Aranda, M. G. Martin, J. H. Doroshow, S. W. Binder, and F.-F. Chu Mice with combined disruption of Gpx1 and Gpx2 genes have colitis Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G848 - G855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. FOX, L. HANDT, S. XU, Z. SHEN, F. E. DEWHIRST, B. J. PASTER, C. A. DANGLER, K. LODGE, S. MOTZEL, and H. KLEIN Novel Helicobacter species isolated from rhesus monkeys with chronic idiopathic colitis J. Med. Microbiol., May 1, 2001; 50(5): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. Lawrance, C. Fiocchi, and S. Chakravarti Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes Hum. Mol. Genet., March 1, 2001; 10(5): 445 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dombrowicz, S. Nutten, P. Desreumaux, C. Neut, G. Torpier, M. Peeters, J.-F. Colombel, and M. Capron Role of the High Affinity Immunoglobulin E Receptor in Bacterial Translocation and Intestinal Inflammation J. Exp. Med., December 27, 2000; 193(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Johnstone, K. M. Tainton, A. A. Ruefli, C. J. Froelich, L. Cerruti, S. M. Jane, and M. J. Smyth P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming Proteins J. Biol. Chem., May 11, 2001; 276(20): 16667 - 16673. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
